PCM
BLFS icon

Palisade Capital Management’s BioLife Solutions BLFS Stock Holding History

Palisade Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.96M Sell
352,737
-405,922
-54% -$9.49M 0.43% 76
2026
Q1 		$14.5M Sell
758,659
-52,351
-6% -$1.16M 0.48% 77
2025
Q4 		$19.6M Sell
811,010
-97,430
-11% -$2.55M 0.58% 62
2025
Q3 		$23.2M Sell
908,440
-11,019
-1% -$261K 0.63% 58
2025
Q2 		$19.8M Sell
919,459
-27,626
-3% -$623K 0.56% 70
2025
Q1 		$21.6M Buy
947,085
+113,937
+14% +$3M 0.62% 61
2024
Q4 		$21.6M Buy
833,148
+12,004
+1% +$299K 0.58% 68
2024
Q3 		$20.6M Sell
821,144
-411,568
-33% -$9.72M 0.55% 73
2024
Q2 		$26.4M Sell
1,232,712
-19,790
-2% -$384K 0.72% 49
2024
Q1 		$23.2M Buy
1,252,502
+39,168
+3% +$685K 0.61% 61
2023
Q4 		$19.7M Sell
1,213,334
-150,304
-11% -$1.92M 0.52% 69
2023
Q3 		$18.8M Buy
1,363,638
+229,286
+20% +$3.61M 0.53% 70
2023
Q2 		$25.1M Buy
1,134,352
+54,538
+5% +$1.15M 0.67% 52
2023
Q1 		$23.5M Buy
1,079,814
+50,191
+5% +$1.13M 0.63% 50
2022
Q4 		$18.7M Buy
1,029,623
+107,080
+12% +$2.21M 0.5% 68
2022
Q3 		$21M Buy
922,543
+2,359
+0.3% +$50.5K 0.59% 55
2022
Q2 		$12.7M Buy
920,184
+368,415
+67% +$5.41M 0.34% 90
2022
Q1 		$12.5M Sell
551,769
-38,219
-6% -$1.01M 0.29% 110
2021
Q4 		$22M Buy
589,988
+5,687
+1% +$244K 0.45% 77
2021
Q3 		$24.7M Buy
584,301
+108,617
+23% +$5.23M 0.54% 64
2021
Q2 		$21.2M Buy
475,684
+96,573
+25% +$3.4M 0.48% 73
2021
Q1 		$13.6M Buy
+379,111
New +$15M 0.32% 110

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Palisade Capital Management's BLFS Position: Q2 2026 in Review

Palisade Capital Management reduced its BioLife Solutions (BLFS) stake by 54% in Q2 2026, selling an estimated $9.49M and leaving 352,737 shares worth $9.96M. The position accounts for 0.43% of the portfolio, ranked #76.

Palisade Capital Management first reported a position in BLFS in Q1 2021 and has held it in 22 quarters since. The position peaked at $26.4M in Q2 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Palisade Capital Management held 352,737 shares of BioLife Solutions worth $9.96M as of Q2 2026.
  • Palisade Capital Management sold 405,922 BioLife Solutions shares in Q2 2026, an estimated $9.49M.
  • BioLife Solutions made up 0.43% of Palisade Capital Management's portfolio in Q2 2026, its #76 holding.
  • Palisade Capital Management first reported a position in BioLife Solutions in Q1 2021 and has held it in 22 quarters since.
  • Palisade Capital Management's BioLife Solutions position peaked at $26.4M in Q2 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Palisade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.